Cargando…
Evolution of lung pathology in lymphangioleiomyomatosis: associations with disease course and treatment response
Lymphangioleiomyomatosis (LAM) is a rare multisystem disease with a variable clinical course. The lungs are infiltrated by nodules of LAM cells, stromal cells and inflammatory cells, causing lung cysts and respiratory failure. We used immunohistochemical markers in lung biopsy and transplant samples...
Autores principales: | Miller, Suzanne, Stewart, Iain D, Clements, Debbie, Soomro, Irshad, Babaei‐Jadidi, Roya, Johnson, Simon R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339164/ https://www.ncbi.nlm.nih.gov/pubmed/32352655 http://dx.doi.org/10.1002/cjp2.162 |
Ejemplares similares
-
Wild Type Mesenchymal Cells Contribute to the Lung Pathology of Lymphangioleiomyomatosis
por: Clements, Debbie, et al.
Publicado: (2015) -
Lung Transplantation for Lymphangioleiomyomatosis in Japan
por: Ando, Katsutoshi, et al.
Publicado: (2016) -
Long-term clinical course and outcomes in patients with lymphangioleiomyomatosis
por: Yoon, Hee-Young, et al.
Publicado: (2022) -
The lung microbiome in end-stage Lymphangioleiomyomatosis
por: Ng, Julie, et al.
Publicado: (2021) -
The vitamin D binding protein axis modifies disease severity in lymphangioleiomyomatosis
por: Miller, Suzanne, et al.
Publicado: (2018)